Trial
NCT05046353
D-serine AudRem: R33 Phase
Phase ISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
Nathan Kline Institute for Psychiatric Research; National Institute of Mental Health (NIMH)
Condition
Schizophrenia
Intervention
D-serine
Why stopped
U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. NKI site is open for enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-29